IRCT20160804029191N4尚未招募3 期
Evaluation of the additive effect of silymarin in the treatment of patients with moderate depression
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients with moderate depression
- •Being 20-50 years old
- •Patient consent to participate in the study
- •Not having specific physical (e.g. cancer, Acquired immunodeficiency syndrome (AIDS), Multiple Sclerosis (MS)) or mental illness
- •Not having allergic to silymarin
- •Not being pregnant/breast feeding
排除标准
- •Lack of patient cooperation in silymarin consumption
- •Having allergic reaction or intolerable side effect caused by silymarin
研究者
相似试验
招募中
3 期
Evaluating the effectiveness of Silymarin on the prevention of gentamicin nephrotoxicityGentamicin-induced renal toxicity in hospitalized patients.Other bacterial diseasesA30-A49IRCT20161010030246N3Shiraz University of Medical Sciences60
尚未招募
2 期
Silymarin capsule in COVID-19COVID-19 disease.COVID-19U07.1IRCT20180103038199N10Mashhad University of Medical Sciences140
招募中
3 期
Investigating the effects of Silymarin in the treatment of neonatal jaundiceIRCT20211122053144N1Mashhad University of Medical Sciences60
已完成
3 期
The effect of silymarin on methadone poisoningIRCT20210216050377N1Shahre-kord University of Medical Sciences64
招募中
不适用
Investigation the effect of herbal supplement on lead concentratiolead poisoning.Abnormal lead level in bloodR78.71IRCT20171122037584N1Hamedan University of Medical Sciences60